Cover Image
市場調查報告書

疫苗遞輸的全球市場分析

Analysis of the Global Vaccines Delivery Market

出版商 Frost & Sullivan 商品編碼 326104
出版日期 內容資訊 英文 82 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
疫苗遞輸的全球市場分析 Analysis of the Global Vaccines Delivery Market
出版日期: 2015年03月13日 內容資訊: 英文 82 Pages
簡介

2014年時,全球疫苗市場只佔醫藥品整體市場的2∼3%左右,不過,這幾年維持著10∼15%高成長率。現在最一般的疫苗遞送方法是注射式,不過,關於成本和安全性殘留大量課題。現在,120種以上的產品在開發平台上,其中60種產品,預期發展中國家將獲得大幅度的銷售額。

本報告提供全球的疫苗遞輸 (疫苗遞送,疫苗給藥) 市場最新趨勢與未來展望相關分析、市場、技術的整體情形和主要的未滿足需求、整體市場趨勢預測 (今後5年份)、各遞送方法的詳細趨勢、今後有潛力的市場領域 (疾病)、各地區的詳細趨勢、今後的技術、產品、市場方向性等調查、考察。

本報告提供以下問題的答案。

  • 疫苗給藥市場是否成長?其持續期及成長率為何?
  • 市場最大的公司為哪3個公司?
  • 市場主要促進、阻礙因素為何?
  • 疫苗給藥市場中最富有魅力的部門為何?
  • 疫苗給藥市場上今後開發、活用的技術為何?

第1章 摘要整理

  • 主要調查結果
  • 主要調查結果:全球疫苗遞輸市場選擇
  • 全球疫苗遞輸市場上的未滿足需求
  • 調查範圍及區分
  • 調查內容
  • 評估
  • CEO全方位展望
  • 值得注意的主要企業
  • 3個主要的預測

第2章 市場概要

  • 市場背景
  • 市場區隔
  • 市場區隔:各疫苗接種方法
  • 各地區的市場區隔,和銷售額前10名的疫苗產品
  • 前五名公司的區分

第3章 競爭策略

  • 新的市場機會
  • 疫苗遞輸系統的開發中產品
  • 疫苗遞輸市場誘因

第4章 市場的推動因素與阻礙因素、趨勢:疫苗遞輸市場整體

  • 推動市場要素
  • 阻礙市場要素

第5章 市場預測與趨勢:疫苗遞輸市場整體

  • 評估
  • 預測的前提條件與定義
  • 收益預測
  • 收益預測:各市場區隔
  • 注射式疫苗遞輸市場概況
  • 注射式疫苗遞輸的主要潛在的市場區隔:流行性感冒
  • 主要的疫苗企業 (民間)
  • 波特的五力分析

第6章 注射式疫苗遞輸市場

  • 評估
  • 收益預測
  • 最新調查結果:注射式疫苗遞輸系統,預計維持一定的需求
  • 競爭評估
  • 注射式疫苗的樂觀預測:肺炎球菌疫苗 (PCV13)

第7章 口服式疫苗遞輸市場

  • 評估
  • 收益預測
  • 收益預測相關考察
  • 競爭評估

第8章 其他疫苗遞輸市場

  • 評估
  • 收益預測
  • 競爭評估
  • 其他疫苗遞輸產品的樂觀預測:經鼻流感噴霧

第9章 新技術及疫苗趨勢:各地區

  • 全球小兒麻庳疫苗趨勢
  • 印度的小兒麻庳疫苗趨勢
  • 美國的新疫苗技術
  • 歐洲的新疫苗技術
  • 其他地區 (亞太地區) 的新疫苗技術

第10章 值得注意的主要企業

  • Becton Dickinson and Company (BD)
  • BioCSL
  • Novavax Inc.
  • Vaxart Inc.
  • Vaxxas

第11章 主要結論

  • 疫苗遞輸系統的未來
  • 主要的結論
  • Frost & Sullivan Awards
  • 免責聲明

第12章 附錄

目錄
Product Code: P875-01-00-00-00

Innovative Technologies and Future Trends for Stakeholders

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immunization more costly and less safe, particularly in resource-poor developing countries. More than 120 new products are currently in the development pipeline, of which sixty hold significant importance to developing nations. The type of delivery system will predict which type of vaccine delivery will remain the most attractive (in terms of revenue) for stakeholders in the next 5 years.

Key Questions This Study Will Answer

  • Is the vaccine delivery market growing? How long will it continue to grow, and at what rate?
  • Which are the top three competitors in this market?
  • What are the major drivers and restraints in this market?
  • Which is the most attractive segment in the total vaccine delivery market?
  • What are the upcoming technologies in the vaccine delivery market?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Findings-Options in the Global Vaccine Delivery Market
  • 4. Unmet Needs in the Global Vaccine Delivery Market
  • 5. Scope and Segmentation
  • 6. Key Questions This Study Will Answer
  • 7. Measurements
  • 8. Measurements (continued)
  • 9. CEO's Perspective
  • 10. Key Companies to Watch
  • 11. Key Companies to Watch (continued)
  • 12. 3 Key Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background
  • 2. Market Segmentation
  • 3. Segmentation by Type of Delivery
  • 4. Segmentation by Region and Top 10 Vaccine Product Sales in 2013
  • 5. Segmentation by Top 5 Competitors

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. New Market Opportunities
  • 2. Pipeline of Vaccine Delivery Systems
  • 3. Attractiveness in Vaccine Delivery Market

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL VACCINE DELIVERY MARKET

Drivers, Restraints, and Trends-Total Vaccine Delivery Market

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Market Restraints
  • 4. Restraints Explained

5. FORECASTS AND TRENDS-TOTAL VACCINE DELIVERY MARKET

Forecasts and Trends-Total Vaccine Delivery Market

  • 1. Measurements
  • 2. Forecast Assumptions and Definitions
  • 3. Revenue Forecast
  • 4. Revenue Forecast by Segment
  • 5. Revenue Forecast Discussion
  • 6. Injectable Vaccine Delivery Market Highlights
  • 7. High Potential Segment for Injectable Vaccine Delivery-Influenza (Flu)
  • 8. Key Vaccine Companies (Private)
  • 9. Porter's Five Force Analysis

6. INJECTABLE VACCINE DELIVERY MARKET

Injectable Vaccine Delivery Market

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Injectable Vaccine Delivery System Expected to Remain in Demand-Results of Recent Survey
  • 5. Competitive Assessment
  • 6. Injectable Vaccine With Promising Future-Pneumococcal Vaccine (PCV13)

7. ORAL VACCINE DELIVERY MARKET

Oral Vaccine Delivery Market

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Competitive Assessment

8. OTHER VACCINE DELIVERIES MARKET

Other Vaccine Deliveries Market

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Competitive Assessment
  • 4. Other Vaccine Deliveries with Promising Future-Intranasal Flu Spray

9. NEW TECHNOLOGIES AND VACCINE TRENDS BY REGION

New Technologies and Vaccine Trends by Region

  • 1. Global-Polio Vaccine Trends
  • 2. India-Polio Vaccine Trends
  • 3. The United States-New Vaccine Technology
  • 4. Europe-New Vaccine Technology
  • 5. Other Regions (APAC)-New Vaccine Technology

10. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. Becton Dickinson and Company (BD)
  • 2. BioCSL
  • 3. Novavax Inc.
  • 4. Vaxart Inc.
  • 5. Vaxxas

11. KEY CONCLUSIONS

Key Conclusions

  • 1. Future of Vaccine Delivery Systems
  • 2. Key Conclusions
  • 3. Frost & Sullivan Awards
  • 4. Legal Disclaimer

12. APPENDIX

Appendix

  • 1. Methodology
  • 2. Learn More-Next Steps
Back to Top